-
Sodium bisulfite
- CAS:7631-90-5
- MW:104.055
- MF:HNaO3S
Sodium bisulfite, with the chemical formula NaHSO3, has the CAS number 7631-90-5. It is a white crystalline powder with a sulfurous odor. Sodium bisulfite is an inorganic compound that consists of one sodium cation (Na+) and one bisulfite anion (HSO3-). This compound is highly soluble in water. It is important to handle sodium bisulfite with caution as it can cause skin and eye irritation. Ingestion or inhalation of sodium bisulfite may cause respiratory and gastrointestinal irritation. It is also important to avoid exposure to high temperatures or open flames, as sodium bisulfite may release toxic fumes. Sodium bisulfite is primarily used as a food preservative and antioxidant. It is also used in the production of paper and pulp, as a reducing agent in various chemical processes, and in water treatment to remove chlorine and prevent oxidation.
Applicable Fields
Food Preservation: Sodium bisulfite is commonly used as a food preservative due to its ability to inhibit the growth of bacteria and other microorganisms. It acts as an antioxidant, preventing the oxidation of food and extending its shelf life.
Paper and Pulp Industry: Sodium bisulfite is used in the production of paper and pulp. It helps to break down lignin, a complex polymer found in wood, and improves the brightness and quality of the paper.
Chemical Processes: Sodium bisulfite is used as a reducing agent in various chemical processes. It can react with certain compounds, such as aldehydes and ketones, to convert them into their corresponding alcohols.
Water Treatment: Sodium bisulfite is used in water treatment to remove chlorine and prevent oxidation. It acts as a chelating agent, binding to metal ions and preventing their precipitation, which can cause scale formation and other water quality issues.
Storage
Conditions: Store in a cool and dry place.
SODIUM BISULFITE? is reported in EPA TSCA Inventory. EPA Genetic Toxicology Program.
Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion. A corrosive irritant to skin, eyes, and mucous membranes. Mutation data reported. An allergen. When heated to decomposition it emits toxic fumes of SOx and Na2O. See also SULFUROUS ACID and SULFITES.
Hazard Codes:?Xn
Risk Statements: 22-31-41?
R22:Harmful if swallowed.?
R31 :Contact with acids liberates toxic gas.?
R41:Risk of serious damage to the eyes.
Safety Statements: 26-39-46-25
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.?
S39:Wear eye / face protection.?
S46:If swallowed, seek medical advice immediately and show this container or label.?
S25:Avoid contact with eyes.
RIDADR: UN 2693
WGK Germany: 1
RTECS: UX8225000
Hazardous Substances Data: 7631-90-5(Hazardous Substances Data)
??Sulfurousacid, sodium salt (1:1) ,?its cas register number is 7631-90-5. It also can be called?AI3-08582 ; Bisulfite de sodium?;?EPA Pesticide Chemical Code 078201 ; Hydrogen sodium sulfite ; Hydrogen sulfite sodium ; Monosodium sulfite ;
?Sodium acid sulfite ; Sodium bisulfite ; Sodium bisulphite ; Sodium hydrogen sulfite ; Sodium hydrosulfite(DOT) ; Sodium metabisulfite ; Sodium sulfite (NaHSO3) ; Sodium sulhydrate ; Sulfurous acid, monosodium salt . Sulfurousacid, sodium salt (1:1) (CAS NO.7631-90-5) is a?white powder.
1. | ??? |
mmo-sat 1?mmol/L |
??? | TCMUD8 ?? Teratogenesis, Carcinogenesis, and Mutagenesis. 5 (1985),195. |
2. | ??? |
mmo-hmi 200?mmol/L ABMPAC 17,115,80 |
||
3. | ??? |
orl-rat LD50:2?g/kg |
??? | 85INA8 ?? Documentation of the Threshold Limit Values and Biological Exposure Indices. 6 (1991),1408. |
4. | ??? |
ipr-rat LD50:475?mg/kg |
??? | PNASA6 ?? Proceedings of the National Academy of Sciences of the United States of America. 70 (1973),3655. |
5. | ??? |
ivn-rat LD50:115?mg/kg |
??? | JPETAB ?? Journal of Pharmacology and Experimental Therapeutics. 101 (1951),101. |
6. | ??? |
ipr-mus LD50:675?mg/kg |
??? | CLPTAT ?? Clinical Pharmacology and Therapeutics. 9 (1968),328. |
7. | ??? |
ivn-mus LD50:130?mg/kg |
??? | JPETAB ?? Journal of Pharmacology and Experimental Therapeutics. 101 (1951),101. |
8. | ??? |
ipr-dog LD50:244?mg/kg |
??? | CLPTAT ?? Clinical Pharmacology and Therapeutics. 9 (1968),328. |
9. | ??? |
ipr-rbt LD50:300?mg/kg |
??? | CLPTAT ?? Clinical Pharmacology and Therapeutics. 9 (1968),328. |
10. | ??? |
ivn-rbt LD50:65?mg/kg |
??? | JPETAB ?? Journal of Pharmacology and Experimental Therapeutics. 101 (1951),101. |